Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies
CA Ricciardi, L Gnudi - Metabolism, 2021 - Elsevier
Metabolic and haemodynamic perturbations and their interaction drive the development of
diabetic kidney disease (DKD) and its progression towards end stage renal disease (ESRD) …
diabetic kidney disease (DKD) and its progression towards end stage renal disease (ESRD) …
Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas
CE Mogensen - The kidney and hypertension in diabetes mellitus, 2004 - taylorfrancis.com
Carl Erik Mogensen Medical Department M, Diabetes and Endocrinology, Aarhus
Kommunehospital, Aarhus University Hospital, Aarhus, Denmark (Modified from …
Kommunehospital, Aarhus University Hospital, Aarhus, Denmark (Modified from …
Regression of microalbuminuria in type 1 diabetes
BA Perkins, LH Ficociello, KH Silva… - … England Journal of …, 2003 - Mass Medical Soc
Background In the present study, we aimed to determine the frequency of a significant
reduction in urinary albumin excretion and factors affecting such reduction in patients with …
reduction in urinary albumin excretion and factors affecting such reduction in patients with …
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study
Objective To evaluate baseline predictors for the development of persistent
microalbuminuria and macroalbuminuria prospectively in patients with type 1 diabetes …
microalbuminuria and macroalbuminuria prospectively in patients with type 1 diabetes …
[HTML][HTML] Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold
N Chaturvedi, S Bandinelli, R Mangili, G Penno… - Kidney international, 2001 - Elsevier
Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold. Background
The occurrence of microalbuminuria in type 1 diabetes is strongly predictive of renal and …
The occurrence of microalbuminuria in type 1 diabetes is strongly predictive of renal and …
Prediction of kidney-related outcomes in patients with type 2 diabetes
MJ Jardine, J Hata, M Woodward, V Perkovic… - American journal of …, 2012 - Elsevier
BACKGROUND: Tools are needed to predict which individuals with diabetes will develop
kidney disease and its complications. STUDY DESIGN: An observational analysis of a …
kidney disease and its complications. STUDY DESIGN: An observational analysis of a …
Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study
F Giorgino, L Laviola, P Cavallo Perin, B Solnica… - Diabetologia, 2004 - Springer
Aims/hypothesis Type 1 diabetic patients who develop microalbuminuria are clearly
disadvantaged in terms of their risk of morbidity and mortality from renal and cardiovascular …
disadvantaged in terms of their risk of morbidity and mortality from renal and cardiovascular …
Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology
G Gruden, PC Perin, G Camussi - Current diabetes reviews, 2005 - ingentaconnect.com
Diabetic nephropathy is characterised by increased glomerular permeability to proteins,
thickening of the glomerular basement membrane, and excessive extracellular matrix …
thickening of the glomerular basement membrane, and excessive extracellular matrix …
Long-term outcomes in youths with diabetes mellitus
NH White - Pediatric Clinics, 2015 - pediatric.theclinics.com
The Diabetes Control and Complications Trial (DCCT) and its ongoing longitudinal
observational follow-up study, the Epidemiology of Diabetes Interventions and …
observational follow-up study, the Epidemiology of Diabetes Interventions and …
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005
P Rossing - Diabetologia, 2006 - Springer
Diabetic nephropathy is a major problem for patients and health care systems. The costs of
treatment remain high. To confront the ongoing challenge, we need to identify individuals at …
treatment remain high. To confront the ongoing challenge, we need to identify individuals at …